首页> 外文期刊>The Internet Journal of Cardiovascular Research >Analysis of nsSNP rs1468384 of NPC1L1 and its association with plasma cholesterol levels in general population
【24h】

Analysis of nsSNP rs1468384 of NPC1L1 and its association with plasma cholesterol levels in general population

机译:普通人群中NPC1L1的nsSNP rs1468384分析及其与血浆胆固醇水平的关系

获取原文
       

摘要

Niemann-Pick C1–like 1 (NPC1L1) protein, a newly identified sterol influx transporter, located at the apical membrane of the enterocyte, which may actively facilitate the uptake of cholesterol by promoting the passage of sterols across the brush border membrane of the enterocyte. It effects intestinal cholesterol absorption and intracellular transport and as such is an integral part of complex process of cholesterol homeostasis. The study of population data for the distribution of these SNPs of NPC1L1 has lead to the identification of six nsSNPs (non-synonymous single nucleotide polymorphism). The in vitro analysis using the software MuPro and StructureSNP shows that nsSNP M510I (rs1468384), which involves A→G base pair change leads to decrease in the stability of the protein. A reproducible and a cost-effective PCR-RFLP based assay was developed to screen for the SNP distribution amongst the North Western Indian population as a test case. This SNP has been studied in Caucasian, Asian and African American populations. Till date, no data is available on Indian population. The allele distribution in Indian Population differs significantly from that of other populations. Moreover on investigating the effect of this nsSNP on the plasma lipid levels in the general population we found a profound association of this nsSNP with higher ranges of plasma lipid levels. Introduction Niemann-Pick C1–like 1 (NPC1L1) protein, a newly identified sterol influx transporter, located at the apical membrane of the enterocyte, which may actively facilitate the uptake of cholesterol by promoting the passage of sterols across the brush border membrane of the enterocyte (1,2). The protein has been characterized by the presence of a signal peptide, 13 putative transmembrane regions, a conserved NPC1 domain and a sterol sensing domain (SSD). Although expressed within several tissues in the body, the expression is predominant in liver and small intestine (3, 4, and 5). In rodents, NPC1L1 is highly expressed on the surface of jejunal absorptive cells whereas in humans the expression is more in the hepatoma cells in the liver (6). The protein plays a key role in cholesterol uptake and intracellular cholesterol trafficking from the plasma membrane to the endoplasmic reticulum (7). A fact further strengthened by the observation of Gracio-Calvo et al., 2005 (8) that the protein was the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorption. Recently Temel et al., 2007 (9) have suggested the presence of NPC1L1 on the canalicular membrane of hepatocytes which may modulate biliary cholesterol excretion. Thus this protein is actively involved in the cholesterol homeostasis pathway (10, 11).Single nucleotide polymorphisms (SNPs), together with copy number variation, are the primary source of variability in the human genome. As amino acid substitutions currently account for approximately half of the known gene lesions responsible for human inherited disease, study of nsSNPs are important in delineating the etiology of many such disorders (12, 13). These SNPs may lead to changes in protein confirmation and may be associated with altered response to drug treatment, susceptibility to disease, and other phenotypic variations (14). The study of population data for the distribution of NPC1L1 has lead to the identification of six nsSNPs (non-synonymous single nucleotide polymorphism). Among the 6 identified nsSNPs, M510I (rs1438384) shows decrease in the stability of the protein as analysed in silico by MuPro (15) and StructureSNP (16) softwares. The M510I polymorphism is the result of a nucleotide change G to A at position 2993 of the cDNA sequence in exon 2, and it results in the substitution of isoleucine for methionine at amino acid 510 of the NPC1L1 protein. The SNP has already been studied in Caucasian, Asian and African American populations by sequencing as given in NCBI database. Till date, no data is available on Indian population. Thus,
机译:Niemann-Pick C1样1(NPC1L1)蛋白是一种新发现的固醇流入转运蛋白,位于肠上皮细胞的顶膜,可通过促进固醇穿过肠上皮刷状缘膜的通道来主动促进胆固醇的吸收。它影响肠道胆固醇的吸收和细胞内运输,因此是胆固醇体内稳态复杂过程不可或缺的一部分。对用于NPC1L1这些SNP分布的种群数据的研究已导致鉴定出六个nsSNP(非同义单核苷酸多态性)。使用软件MuPro和StructureSNP进行的体外分析表明,涉及A→G碱基对变化的nsSNP M510I(rs1468384)导致蛋白质稳定性降低。开发了一种可重复且具有成本效益的基于PCR-RFLP的检测方法,以筛选SNP在西北印度人口中的分布作为测试案例。已经在白种人,亚裔和非裔美国人人群中研究了此SNP。截至目前,尚无印度人口数据。印度人口中的等位基因分布与其他人口有显着差异。此外,在调查该nsSNP对普通人群血浆脂质水平的影响时,我们发现该nsSNP与更高范围的血浆脂质水平有着深远的联系。简介Niemann-Pick C1样1(NPC1L1)蛋白是一种新发现的固醇流入转运蛋白,位于肠上皮细胞的顶膜,可通过促进固醇穿过脂质体刷状缘膜的通道来主动促进胆固醇的吸收。肠上皮细胞(1,2)。该蛋白的特征在于存在信号肽,13个推定的跨膜区,一个保守的NPC1域和一个固醇传感域(SSD)。尽管在体内的几个组织中表达,但该表达主要在肝脏和小肠中(3、4和5)。在啮齿动物中,NPC1L1在空肠吸收细胞的表面高度表达,而在人类中,其在肝脏的肝癌细胞中的表达更多(6)。该蛋白在胆固醇摄取和细胞内胆固醇从质膜到内质网的运输中起着关键作用(7)。 Gracio-Calvo et al。,2005(8)的观察进一步证实了该蛋白是依泽替米贝的直接分子靶标,后者是抑制胆固醇吸收的药物。最近,Temel等人(2007年)(9)提出,肝细胞小管膜上存在NPC1L1,这可能会调节胆汁胆固醇的排泄。因此,这种蛋白质积极参与胆固醇的稳态途径(10、11)。单核苷酸多态性(SNP)以及拷贝数变异是人类基因组变异的主要来源。由于氨基酸置换目前约占导致人类遗传疾病的已知基因损伤的一半,因此对nsSNPs的研究对于描述许多此类疾病的病因非常重要(12、13)。这些SNP可能导致蛋白质确认的改变,并可能与对药物治疗的反应改变,对疾病的敏感性以及其他表型变异有关(14)。对人口数据中NPC1L1分布的研究已导致鉴定出六个nsSNP(非同义单核苷酸多态性)。在6个已鉴定的nsSNP中,M510I(rs1438384)显示出该蛋白的稳定性下降,这是通过MuPro(15)和StructureSNP(16)软件进行的计算机分析。 M510I多态性是外显子2中cDNA序列第2993位核苷酸G变为A的结果,它导致NPC1L1蛋白第510位氨基酸的异亮氨酸被蛋氨酸取代。已经通过NCBI数据库中给出的测序方法对高加索人,亚裔和非洲裔美国人的SNP进行了研究。截至目前,尚无印度人口数据。从而,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号